Response: Re: Dose Escalation Methods in Phase I Cancer Clinical Trials

被引:1
|
作者
Le Tourneau, Christophe
Lee, J. Jack
Siu, Lillian L.
机构
关键词
D O I
10.1093/jnci/djp401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1733 / 1734
页数:2
相关论文
共 50 条
  • [1] Dose Escalation Methods in Phase I Cancer Clinical Trials
    Le Tourneau, Christophe
    Lee, J. Jack
    Siu, Lillian L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 708 - 720
  • [2] Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control
    Tighiouart, M
    Rogatko, A
    Babb, JS
    STATISTICS IN MEDICINE, 2005, 24 (14) : 2183 - 2196
  • [3] Cancer phase I clinical trials: Efficient dose escalation with overdose control
    Babb, J
    Rogatko, A
    Zacks, S
    STATISTICS IN MEDICINE, 1998, 17 (10) : 1103 - 1120
  • [4] EWOC 2.0: Interactive software for dose escalation in cancer phase I clinical trials
    Xu, Zhiheng
    Tighiouart, Mourad
    Rogatko, Andre
    DRUG INFORMATION JOURNAL, 2007, 41 (02): : 221 - 228
  • [5] EWOC 2.0: Interactive Software for Dose Escalation in Cancer Phase I Clinical Trials
    Zhiheng Xu
    Mourad Tighiouart
    André Rogatko
    Drug information journal : DIJ / Drug Information Association, 2007, 41 : 221 - 228
  • [6] GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
    D. Dinart
    J. Fraisse
    D. Tosi
    A. Mauguen
    C. Touraine
    S. Gourgou
    M. C. Le Deley
    C. Bellera
    C. Mollevi
    BMC Medical Informatics and Decision Making, 20
  • [7] GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
    Dinart, D.
    Fraisse, J.
    Tosi, D.
    Mauguen, A.
    Touraine, C.
    Gourgou, S.
    Le Deley, M. C.
    Bellera, C.
    Mollevi, C.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
  • [8] Optimal Bayesian-feasible dose escalation for cancer phase I trials
    Zacks, S
    Rogatko, A
    Babb, J
    STATISTICS & PROBABILITY LETTERS, 1998, 38 (03) : 215 - 220
  • [9] Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control
    Tighiouart, Mourad
    Piantadosi, Steven
    Rogatko, Andre
    STATISTICS IN MEDICINE, 2014, 33 (22) : 3815 - 3829
  • [10] AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials
    Zhou, Yanhong
    Zhao, Yujie
    Cicconetti, Greg
    Mu, Yunming
    Yuan, Ying
    Wang, Li
    Penugonda, Sudhir
    Salman, Zeena
    PHARMACEUTICAL STATISTICS, 2023, 22 (02) : 300 - 311